Skip to main content

Featured

  Thursday, July 9, 2026  Every July, a wave of federal benefit payments resets for the new benefit year — and 2026 brings one of the biggest shifts in years. Between a permanent 25% boost to the old GST/HST credit, a fresh Canada Child Benefit increase, and the largest quarterly OAS bump of the year, millions of Canadian households will see different numbers land in their accounts this month. Here's what actually changed, and what to check in your own CRA account. The GST/HST Credit Has a New Name — and a Bigger Payout The GST/HST credit has officially been replaced by the Canada Groceries and Essentials Benefit (CGEB) . It's not a new program from scratch — it runs on the same CRA infrastructure and eligibility rules — but the payment amounts are 25% higher, and that increase is locked in for five years. The first CGEB payment went out on July 3, 2026. Under the new structure: A single individual with no children can receive up to roughly $679 per year (about $170 per quart...

article

Cancer-Causing Chemical Detected in Acne Treatments: Brands Under Scrutiny

 


In a recent alarming discovery, independent U.S. laboratory Valisure has detected high levels of the cancer-causing chemical benzene in certain acne treatments. Brands affected include:

  1. Clinique (Estee Lauder)
  2. Clearasil (Reckitt Benckiser-owned)
  3. Proactiv
  4. Target Corp.'s Up & Up
  5. PanOxyl
  6. Walgreens’ acne soap bar
  7. Walmart’s Equate Beauty acne cream

Benzene, a known carcinogen, was found not only in the acne products themselves but also in the air around incubated products, suggesting a potential inhalation risk. Valisure has filed a petition with the U.S. Food and Drug Administration (FDA) urging product recalls, investigations, and revised industry guidance. The situation is substantially different from previous cases where benzene impurities came from contaminated ingredients. Here, benzene originates directly from the benzoyl peroxide itself, forming at unacceptably high levels.

Consumers are advised to stay informed as regulatory responses unfold. The FDA’s reaction to Valisure’s petition remains pending. Companies implicated in this issue, including Estee Lauder, have yet to respond to media inquiries.

As we await further developments, it’s crucial to prioritize safety and informed choices when it comes to skincare products. 









Comments